Neuronal Development and Onset of Electrical Activity in the Human Enteric Nervous System.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 29 04 2018
revised: 07 12 2018
accepted: 24 12 2018
pubmed: 6 1 2019
medline: 6 5 2019
entrez: 6 1 2019
Statut: ppublish

Résumé

The enteric nervous system (ENS) is the largest branch of the peripheral nervous system, comprising complex networks of neurons and glia, which are present throughout the gastrointestinal tract. Although development of a fully functional ENS is required for gastrointestinal motility, little is known about the ontogeny of ENS function in humans. We studied the development of neuronal subtypes and the emergence of evoked electrical activity in the developing human ENS. Human fetal gut samples (obtained via the MRC-Wellcome Trust Human Developmental Biology Resource-UK) were characterized by immunohistochemistry, calcium imaging, RNA sequencing, and quantitative real-time polymerase chain reaction analyses. Human fetal colon samples have dense neuronal networks at the level of the myenteric plexus by embryonic week (EW) 12, with expression of excitatory neurotransmitter and synaptic markers. By contrast, markers of inhibitory neurotransmitters were not observed until EW14. Electrical train stimulation of internodal strands did not evoke activity in the ENS of EW12 or EW14 tissues. However, compound calcium activation was observed at EW16, which was blocked by the addition of 1 μmol/L tetrodotoxin. Expression analyses showed that this activity was coincident with increases in expression of genes encoding proteins involved in neurotransmission and action potential generation. In analyses of human fetal intestinal samples, we followed development of neuronal diversity, electrical excitability, and network formation in the ENS. These processes are required to establish the functional enteric circuitry. Further studies could increase our understanding of the pathogenesis of a range of congenital enteric neuropathies.

Sections du résumé

BACKGROUND & AIMS OBJECTIVE
The enteric nervous system (ENS) is the largest branch of the peripheral nervous system, comprising complex networks of neurons and glia, which are present throughout the gastrointestinal tract. Although development of a fully functional ENS is required for gastrointestinal motility, little is known about the ontogeny of ENS function in humans. We studied the development of neuronal subtypes and the emergence of evoked electrical activity in the developing human ENS.
METHODS METHODS
Human fetal gut samples (obtained via the MRC-Wellcome Trust Human Developmental Biology Resource-UK) were characterized by immunohistochemistry, calcium imaging, RNA sequencing, and quantitative real-time polymerase chain reaction analyses.
RESULTS RESULTS
Human fetal colon samples have dense neuronal networks at the level of the myenteric plexus by embryonic week (EW) 12, with expression of excitatory neurotransmitter and synaptic markers. By contrast, markers of inhibitory neurotransmitters were not observed until EW14. Electrical train stimulation of internodal strands did not evoke activity in the ENS of EW12 or EW14 tissues. However, compound calcium activation was observed at EW16, which was blocked by the addition of 1 μmol/L tetrodotoxin. Expression analyses showed that this activity was coincident with increases in expression of genes encoding proteins involved in neurotransmission and action potential generation.
CONCLUSIONS CONCLUSIONS
In analyses of human fetal intestinal samples, we followed development of neuronal diversity, electrical excitability, and network formation in the ENS. These processes are required to establish the functional enteric circuitry. Further studies could increase our understanding of the pathogenesis of a range of congenital enteric neuropathies.

Identifiants

pubmed: 30610864
pii: S0016-5085(18)35435-0
doi: 10.1053/j.gastro.2018.12.020
pii:
doi:

Substances chimiques

Neurotransmitter Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1483-1495.e6

Subventions

Organisme : Medical Research Council
ID : G0800973
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R006237/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 099175/Z/12/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : 099175/Z/12/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Conor J McCann (CJ)

Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.

Maria M Alves (MM)

Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.

Erwin Brosens (E)

Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.

Dipa Natarajan (D)

Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.

Silvia Perin (S)

Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.

Chey Chapman (C)

Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.

Robert M Hofstra (RM)

Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, London, UK; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.

Alan J Burns (AJ)

Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, London, UK; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.

Nikhil Thapar (N)

Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, London, UK; Prince Abdullah Ben Khalid Celiac Research Chair, College of Medicine, King Saud University, Riyadh, KSA; Department of Gastroenterology, Great Ormond Street Hospital, London, UK. Electronic address: n.thapar@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH